Literature DB >> 28878352

S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells.

K Vrzalikova1, M Ibrahim1, M Vockerodt1,2, T Perry1, S Margielewska1, L Lupino1, E Nagy1, E Soilleux3, D Liebelt1, R Hollows1, A Last1, G Reynolds4, M Abdullah1,5, H Curley1, M Care6, D Krappmann7, R Tooze6, J Allegood8, S Spiegel8, W Wei1,9, C B J Woodman1, P G Murray1,10.   

Abstract

The Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma (HL) are characterised by the aberrant activation of multiple signalling pathways. Here we show that a subset of HL displays altered expression of sphingosine-1-phosphate (S1P) receptors (S1PR)s. S1P activates phosphatidylinositide 3-kinase (PI3-K) in these cells that is mediated by the increased expression of S1PR1 and the decreased expression of S1PR2. We also showed that genes regulated by the PI3-K signalling pathway in HL cell lines significantly overlap with the transcriptional programme of primary HRS cells. Genes upregulated by the PI3-K pathway included the basic leucine zipper transcription factor, ATF-like 3 (BATF3), which is normally associated with the development of dendritic cells. Immunohistochemistry confirmed that BATF3 was expressed in HRS cells of most HL cases. In contrast, in normal lymphoid tissues, BATF3 expression was confined to a small fraction of CD30-positive immunoblasts. Knockdown of BATF3 in HL cell lines revealed that BATF3 contributed to the transcriptional programme of primary HRS cells, including the upregulation of S1PR1. Our data suggest that disruption of this potentially oncogenic feedforward S1P signalling loop could provide novel therapeutic opportunities for patients with HL.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28878352      PMCID: PMC5737877          DOI: 10.1038/leu.2017.275

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  59 in total

1.  Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein.

Authors:  M Iacobelli; W Wachsman; K L McGuire
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells.

Authors:  Hongya Han; Yongtao Xue-Franzén; Xinyan Miao; Edit Nagy; Nailin Li; Dawei Xu; Jan Sjöberg; Magnus Björkholm; Hans-Erik Claesson
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-06-23       Impact factor: 3.072

3.  Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma.

Authors:  Franziska Jundt; Ioannis Anagnostopoulos; Reinhold Förster; Stephan Mathas; Harald Stein; Bernd Dörken
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

Review 4.  Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics.

Authors:  Sheldon Milstien; Sarah Spiegel
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

5.  Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.

Authors:  Joanne R Flavell; Karl R N Baumforth; Victoria H J Wood; Gillian L Davies; Wenbin Wei; Gary M Reynolds; Susan Morgan; Andrew Boyce; Gemma L Kelly; Lawrence S Young; Paul G Murray
Journal:  Blood       Date:  2007-08-24       Impact factor: 22.113

6.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Authors:  Kayo Arikawa; Noriko Takuwa; Hironori Yamaguchi; Naotoshi Sugimoto; Joji Kitayama; Hirokazu Nagawa; Kazuhiko Takehara; Yoh Takuwa
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

7.  Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.

Authors:  Christian Steidl; Arjan Diepstra; Tang Lee; Fong Chun Chan; Pedro Farinha; King Tan; Adele Telenius; Lorena Barclay; Sohrab P Shah; Joseph M Connors; Anke van den Berg; Randy D Gascoyne
Journal:  Blood       Date:  2012-09-05       Impact factor: 22.113

8.  Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.

Authors:  Nitai C Hait; Jeremy Allegood; Michael Maceyka; Graham M Strub; Kuzhuvelil B Harikumar; Sandeep K Singh; Cheng Luo; Ronen Marmorstein; Tomasz Kordula; Sheldon Milstien; Sarah Spiegel
Journal:  Science       Date:  2009-09-04       Impact factor: 47.728

9.  Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.

Authors:  Katerina Vrzalikova; Sarah Leonard; Yichao Fan; Andrew Bell; Martina Vockerodt; Patrik Flodr; Kenneth L Wright; Martin Rowe; Qian Tao; Paul G Murray
Journal:  Pathogens       Date:  2012-10-08

10.  The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.

Authors:  James Heather; Kirsty Flower; Samine Isaac; Alison J Sinclair
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more
  12 in total

Review 1.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

Review 2.  An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.

Authors:  Akira Satou; Taishi Takahara; Shigeo Nakamura
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

3.  Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitment.

Authors:  Y Lin; L Cheng; Y Liu; Y Wang; Q Wang; H L Wang; G Shi; J S Li; Q N Wang; Q M Yang; S Chen; X L Su; Y Yang; M Jiang; X Hu; P Fan; C Fang; Z G Zhou; L Dai; H X Deng
Journal:  Mucosal Immunol       Date:  2020-05-28       Impact factor: 7.313

4.  Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas.

Authors:  Mustafa Al-Kawaaz; Teresa Sanchez; Michael J Kluk
Journal:  J Hematop       Date:  2019-04-27       Impact factor: 0.196

Review 5.  New developments in the pathology of malignant lymphoma. A review of the literature published from September-August 2017.

Authors:  J H van Krieken
Journal:  J Hematop       Date:  2017-11-29       Impact factor: 0.196

6.  Ectopic expression of transcription factor BATF3 induces B-cell lymphomas in a murine B-cell transplantation model.

Authors:  Christian Weiser; Mina V Petkova; Benjamin Rengstl; Claudia Döring; Dorothee von Laer; Sylvia Hartmann; Ralf Küppers; Martin-Leo Hansmann; Sebastian Newrzela
Journal:  Oncotarget       Date:  2018-03-23

Review 7.  Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma.

Authors:  Katerina Vrzalikova; Taofik Sunmonu; Gary Reynolds; Paul Murray
Journal:  Pathogens       Date:  2018-06-27

8.  S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.

Authors:  Yan Liu; Yingru Zhi; Haizhu Song; Mingzhu Zong; Jun Yi; Guoxin Mao; Longbang Chen; Guichun Huang
Journal:  J Exp Clin Cancer Res       Date:  2019-08-22

9.  Sphingosine-1-phosphate signalling drives an angiogenic transcriptional programme in diffuse large B cell lymphoma.

Authors:  Lauren Lupino; Tracey Perry; Sandra Margielewska; Robert Hollows; Maha Ibrahim; Matthew Care; Jeremy Allegood; Reuben Tooze; Roger Sabbadini; Gary Reynolds; Roy Bicknell; Zbigniew Rudzki; Ye Lin Hock; Ulises Zanetto; Wenbin Wei; William Simmons; Sarah Spiegel; Ciaran B J Woodman; Martin Rowe; Katerina Vrzalikova; Paul G Murray
Journal:  Leukemia       Date:  2019-05-16       Impact factor: 11.528

Review 10.  AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL.

Authors:  Zuoqiao Wu; Mary Nicoll; Robert J Ingham
Journal:  Exp Hematol Oncol       Date:  2021-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.